RxDoctor Payments Data

Matthew Radant, MD

Oral & Maxillofacial Surgery · Tulsa, OKNPI 1316226087

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,518 of the $5,804 with a category attached, or 77.8%. 15 manufacturers reported payments, led by Axogen at 53.9% of the total. Reporting peaked in 2023 at $2,440 and has fallen 81.5% since, to $452 in 2025.

$5,804in general payments, 2019–2025

Across 67 payments — averaging $86.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axogen$3K
  • Kls-martin L.p.$2K
  • Stryker$339
  • Acera Surgical, Inc.$280
  • Johnson & Johnson$100
  • Zimmer Biomet$75
  • plus $219 from 9 others

What the payments were for

  • Travel & lodging$1,21221%
  • Food & beverage$4,51878%
  • Education$751%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,804 in reported general payments places this provider in the 85th percentile of 81 oral & maxillofacial surgery providers in Oklahoma.

See all oral & maxillofacial surgery providers in Oklahoma

Medicare billing

Part B allowed, 2024
$134,103
Medicare patients
127
Services billed
435

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Chlorhexidine Gluconate193$854
Pentoxifylline33$724
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen88$562
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav34$385
Lidocaine Hcl ViscousLidocaine Hcl27$342
Nystatin24$286
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen56$266
Pregabalin20$260
Dexamethasone22$187
Methylprednisolone12$100
Ibuprofen11$93
Tizanidine Hcl12$69
Levofloxacin11$65
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$54

Paid to pharmacies, not to this prescriber.

Other oral & maxillofacial surgery in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →